JPRN-UMIN000010485已完成2 期
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma - Biweekly THP-COP for PTCLs
Yokohama City University Hopsital0 个研究点目标入组 20 人开始时间: 2013年4月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria were the presence of serious infection; active tuberculosis; diabetes mellitus uncontrollable with insulin, liver cirrhosis, arrhythmia, or other abnormal electrocardiographic finding requiring treatment, concomitant malignant disease other than basal cell carcinoma of the skin or carcinoma in situ of the uteric cervix; central nervous system (CNS) lymphoma; pregnancy or breast feeding; mental disorders; and positivity for hepatitis B surface antigen, human T-lymphotrophic virus-1 antibody, or human immunodeficiency virus antibody. Patients were also excluded if the treating physician considered the protocol too difficult for the patients to carry out.
研究者
相似试验
招募中
2 期
Phase II trial of biweekly THP-COP therapy for patients with peripheral T-cell lymphomas.Peripheral T-cell lymphomas (PTCL,nos, AITL, ALK-negative ALCL)JPRN-UMIN000018919Kanagawa Clinical Oncology study Group40
已完成
2 期
Phase II study of a full-dose THP-COP regimen for aggressive non-Hodgkin lymphoma in the elderlyJPRN-UMIN000005636Hematological Malignancy Clinical Study Group30
已完成
不适用
Efficacy of once weekly teriparatide in patients with glucocorticoid-induced osteoporosisJPRN-UMIN000011419Glucocorticoid-induced osteoporosis research group204
已完成
不适用
Prospective cohort study of standard therapy for primary malignant brain tumor patientJPRN-UMIN000030170Japan Photodynamic Neurosurgical Society100
尚未招募
4 期
WHO-Recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in KenyaPACTR202407778358273ational Institute of Allergy and Infectious Diseases2,900